421 results
8-K
EX-99.2
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
This presentation contains statements about Bristol-Myers Squibb Company’s (the “Company”) future financial results, plans, business development strategy
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
strategy, and its long-term aspirational ESG goals. The company's evolved approach further integrates its ESG strategy and its business strategy … . The ESG strategy focuses on three core pillars: advancing patient health around the world, expanding the boundaries of science, and fostering a high
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
2022 -2% versus 2022 Balanced Capital Allocation Strategy $13.9B 5.6% $5.2B in cash flow from quarterly dividend increase share repurchase operating … items excluded from non-GAAP EPS.
5 Progressing our ESG Strategy and Health Equity Initiatives INCLUSION & DIVERSITY Executive representation
424B5
vzual9j
16 Feb 24
Prospectus supplement for primary offering
4:34pm
424B2
lcv2 chnj
13 Feb 24
Prospectus for primary offering
8:00am
8-K
EX-99.2
e5790 d8d
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
8-K
EX-99.1
dm7icaou0
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
j6oeu1
25 Jan 24
Third party tender offer statement
8:13am
8-K
EX-99.1
benha
8 Jan 24
Regulation FD Disclosure
10:29am
DFAN14A
35sfd6el
22 Dec 23
Additional proxy materials by non-management
4:36pm
424B5
evz7ese qnpc
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
wk4l8 v0wuabk
30 Oct 23
Prospectus supplement
8:05am
8-K
EX-99.2
4meo6e
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
EX-99.1
telzqo
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
DFAN14A
2c90mliglr
10 Oct 23
Additional proxy materials by non-management
6:48am